L
Lite Strategy, Inc. (LITS)
NCM – Real Time Price. Currency in USD
0.90
+0.08 (9.89%)
At close: Jun 26, 2026, 4:00 PM EDT
0.88
-0.02 (-1.78%)
After-hours: Jun 26, 2026, 5:23 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
0.90
+0.08 (9.89%)
At close: Jun 26, 2026, 4:00 PM EDT
0.88
-0.02 (-1.78%)
After-hours: Jun 26, 2026, 5:23 PM EDT
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
| Name | Position |
|---|---|
| Dr. Robert D. Mass M.D. | Strategic Advisor |
| Mr. Justin J. File CPA | CEO, CFO, Corporate Secretary & Director |
| Ms. Anne Frese | Chief People Officer |
| Date | Type | Document |
|---|---|---|
| 2026-05-13 | 8-K | lits-20260513.htm |
| 2026-05-13 | 10-Q | lits-20260331.htm |
| 2026-02-17 | 8-K | lits-20260217.htm |
| 2026-02-17 | 10-Q | lits-20251231.htm |
| 2026-02-12 | 8-K | lits-20260212.htm |
| 2026-01-27 | DEFA14A | defa14a.htm |
| 2025-12-30 | DEFA14A | lits-20251229.htm |
| 2025-12-30 | DEF 14A | lits-20251230.htm |
| 2025-12-30 | 8-K | lits-20251223.htm |
| 2025-12-05 | 8-K | lits-20251202.htm |